LARVOL Revenue and Competitors

Location

N/A

Total Funding

Analytics

Industry

Estimated Revenue & Valuation

  • LARVOL's estimated annual revenue is currently $24.2M per year.(i)
  • LARVOL's estimated revenue per employee is $154,000

Employee Data

  • LARVOL has 157 Employees.(i)
  • LARVOL grew their employee count by -12% last year.

LARVOL's People

NameTitleEmail/Phone
1
VP, OncologyReveal Email/Phone
2
VP - Product ManagementReveal Email/Phone
3
VP, Global OperationsReveal Email/Phone
4
Director - KOL & Life Sciences StrategyReveal Email/Phone
5
Director Product DevelopmentReveal Email/Phone
6
Senior Customer Success ManagerReveal Email/Phone
7
Product Design ManagerReveal Email/Phone
8
Associate ManagerReveal Email/Phone
9
Associate ManagerReveal Email/Phone
10
Associate ManagerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$1.4M17N/AN/AN/A
#2
$0.6M80%N/AN/A
#3
$13.2M946%N/AN/A
#4
$78.4M4410%$6.8MN/A
#5
$12M86-1%N/AN/A
#6
$66.1M372-3%$131.5MN/A
#7
$0.6M8-50%N/AN/A
#8
$0.3M433%N/AN/A
#9
$0.6M9N/AN/AN/A
#10
$2.6M27N/AN/AN/A
Add Company

What Is LARVOL?

Customized intelligence reports and SaaS solutions - We provide healthcare and life sciences experts accurate, rapid, expertly-curated information to enable strategic decision-making. Our products include KOL monitoring, real-time high-impact news, intuitive cancer biomarker database and comprehensive conference planners. To keep you at the forefront of clinical and industry developments, LARVOL curates pharmaceutical and biotech competitive intelligence using a proven combination of broad therapeutic-area expertise and technological innovation. Our team of MDs and PhDs collates data from over 25,000 sources and distills the most relevant findings into concise reports that provide real-time insights and time-saving analysis. Our global team is comprised of professionals with expertise in all major therapeutic areas, with a special focus on oncology, inflammation, cardiovascular, and CNS. We are a valued partner to numerous Fortune 500 companies as well as small and mid-size pharma and biotech enterprises.

keywords:N/A

N/A

Total Funding

157

Number of Employees

$24.2M

Revenue (est)

-12%

Employee Growth %

N/A

Valuation

N/A

Accelerator

LARVOL News

2021-02-23 - LARVOL Appoints New Vice President, Global Sales

SAN FRANCISCO--(BUSINESS WIRE)--Feb 23, 2021-- LARVOL, leading provider of intelligence and data solutions to pharma and life science teams, today welcomes Mark Lagunowich as Vice President, Global Sales. “We are thrilled to welcome Mark to the team at LARVOL,” said founder and CEO Bruno Larvo ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$30.4M157-5%$335M
#2
$7.5M15722%N/A
#3
$46.6M1578%N/A
#4
$36.3M1578%N/A
#5
$22.1M1584%$40M